TY - JOUR
T1 - Acceptability and willingness to pay for a hypothetical vaccine against SARS CoV-2 by the Brazilian consumer
T2 - a cross-sectional study and the implications
AU - Godói, Isabella Piassi Dias
AU - Sarmento, Túlio Tadeu Rocha
AU - Reis, Edna Afonso
AU - Gargano, Ludmila Peres
AU - Godman, Brian
AU - Acurcio, Francisco de Assis
AU - Alvares-Teodoro, Juliana
AU - Guerra Júnior, Augusto Afonso
AU - Ruas, Cristina Mariano
PY - 2022/1/13
Y1 - 2022/1/13
N2 - Introduction: The new coronavirus pandemic has appreciably impacted on morbidity and mortality as well as having appreciable economic impact worldwide. New vaccines are a potential way forward to reduce transmission rates and their subsequent impact. In Brazil vaccines are being distributed via the public sector. In the future, vaccines will be available in the private market. Information about consumers' willingness to pay (WTP) for a hypothetical vaccine against SARS CoV-2 can help future price setting discussions. Methods: A cross-sectional study was conducted with consumers in the five regions of Brazil regarding the willingness to pay (WTP) for a hypothetical vaccine against SARS CoV-2 with a 50% efficacy. Results: A total of 1402 individuals over 18 years of age who declared not having COVID-19 at the time of the survey were interviewed. The acceptability for this hypothetical vaccine was 80.7%. In addition, the amount of WTP by Brazilian consumers for a hypothetical SARS CoV-2 vaccine was estimated at US$ 22.18(120.00 BRL). Conclusion: This study can contribute to decision-making to inform potential pricing for a hypothetical SARS CoV-2 vaccine.
AB - Introduction: The new coronavirus pandemic has appreciably impacted on morbidity and mortality as well as having appreciable economic impact worldwide. New vaccines are a potential way forward to reduce transmission rates and their subsequent impact. In Brazil vaccines are being distributed via the public sector. In the future, vaccines will be available in the private market. Information about consumers' willingness to pay (WTP) for a hypothetical vaccine against SARS CoV-2 can help future price setting discussions. Methods: A cross-sectional study was conducted with consumers in the five regions of Brazil regarding the willingness to pay (WTP) for a hypothetical vaccine against SARS CoV-2 with a 50% efficacy. Results: A total of 1402 individuals over 18 years of age who declared not having COVID-19 at the time of the survey were interviewed. The acceptability for this hypothetical vaccine was 80.7%. In addition, the amount of WTP by Brazilian consumers for a hypothetical SARS CoV-2 vaccine was estimated at US$ 22.18(120.00 BRL). Conclusion: This study can contribute to decision-making to inform potential pricing for a hypothetical SARS CoV-2 vaccine.
KW - SARS CoV-2
KW - code review
KW - willingness to pay
KW - vaccine
KW - Brazil
KW - contingent valuation
U2 - 10.1080/14737167.2021.1931128
DO - 10.1080/14737167.2021.1931128
M3 - Article
SN - 1473-7167
VL - 22
SP - 119
EP - 129
JO - Expert Review of Pharmacoeconomics and Outcomes Research
JF - Expert Review of Pharmacoeconomics and Outcomes Research
IS - 1
ER -